FAKTOR-OPTIONSSCHEIN - DEXCOM Share Price

DE000MG2CAX1

Real-time Bid/Ask 05:25:44 04/06/2024 pm IST
24.91 ^EUR / 26.65 ^EUR	+41.42%

Current month	-6.13%
1 month	+16.41%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes	04:34pm	BU
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems	04/06	BU
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems	04/06	CI
Redburn Atlantic Initiates DexCom With Neutral Rating, $130 Price Target	30/05	MT

More news

Quotes 5-day view

Date	Price	Change
04/24/04	25.03	+37.30%
03/24/03	18.23	-6.13%
31/24/31	19.42	+70.95%
30/24/30	11.36	+0.71%
29/24/29	11.28	-1.40%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 03:54 pm IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	Morgan Stanley
WKN	MG2CAX
ISIN	DE000MG2CAX1
Date issued	15/04/2024
Strike	126.8 $
Maturity	Unlimited
Parity	0.44 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	25.03 €
Lowest since issue	8.63 €
Spread	1.81 €
Spread %	6.77%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

115.2 USD

Average target price

150.3 USD

Spread / Average Target

+30.47%

Consensus